Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial

Journal:
The Lancet
Published:
Affiliations:
45
Authors:
41
Institutions Authors Share
Agostino Gemelli University Polyclinic, Italy
4.000000
0.10
Corcept Therapeutics, United States of America (USA)
4.000000
0.10
Humanitas San Pio X Hospital, Italy
1.500000
0.04
ARCAGY-GINECO, France
1.500000
0.04
Kore University of Enna, Italy
1.500000
0.04
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA)
1.000000
0.02
Seoul National University (SNU), South Korea
1.000000
0.02
Fundación Estudios Clínicos, Argentina
1.000000
0.02
McGill University Health Centre (MUHC), Canada
1.000000
0.02
Peter MacCallum Cancer Centre (Peter Mac), Australia
1.000000
0.02
Medical College of Wisconsin (MCW), United States of America (USA)
1.000000
0.02
Yonsei University, South Korea
1.000000
0.02
Hospital Universitario Puerta de Hierro Majadahonda, UAM, Spain
1.000000
0.02
Hospital Nove de Julho, Brazil
1.000000
0.02
Samsung Medical Center (SMC), South Korea
1.000000
0.02
Virginia Oncology Associates, United States of America (USA)
1.000000
0.02
Royal North Shore Hospital (RNSH), Australia
1.000000
0.02
National Institute of Oncology (NIO), Hungary
1.000000
0.02
Rutgers Cancer Institute of New Jersey (CINJ), United States of America (USA)
1.000000
0.02
Florida Cancer Specialists and Research Institute (FCS), United States of America (USA)
1.000000
0.02
Stanford University, United States of America (USA)
1.000000
0.02
Mount Sinai Medical Center (MSMC), United States of America (USA)
1.000000
0.02
Lorraine Institute of Oncology (ICL), France
1.000000
0.02
Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Belgium
1.000000
0.02
Azienda ULSS 2 Marca Trevigiana, Italy
1.000000
0.02
Health Research Institute (IIS La Fe), Spain
1.000000
0.02
IRCCS European Institute of Oncology (IEO), Italy
1.000000
0.02
Humanitas University, Italy
0.500000
0.01
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France
0.500000
0.01
Institut du Cancer de Montpellier (ICM), France
0.500000
0.01
The Christie NHS Foundation Trust, United Kingdom (UK)
0.500000
0.01
The University of Manchester (UoM), United Kingdom (UK)
0.500000
0.01
Centre Antoine-Lacassagne (CAL), France
0.500000
0.01
Grand Hôpital de Charleroi (GHdC), Belgium
0.500000
0.01
Azienda Ospedaliera Cannizzaro - Catania, Italy
0.500000
0.01
University of Pavia (UNIPV), Italy
0.500000
0.01
IRCCS Policlinico San Matteo, Italy
0.500000
0.01
University Hospitals Leuven (UZ Leuven), Belgium
0.500000
0.01
University of Pittsburgh (Pitt), United States of America (USA)
0.500000
0.01
UPMC Magee-Womens Hospital, United States of America (USA)
0.500000
0.01